UEI: JJ1KXAGP4CQ3 • CAGE: L06J9

IBEX Pharmaceuticals Inc (QC)

Registration and award facts

SAM.gov registration as of Oct 3, 2026

Net obligations since FY2013: $5.85K; $5,850under this UEI
FY2026 obligations: $0; Provisional
Awards and orders: 1; with positive net obligations
Latest action: Jul 28, 2013
SAM.gov registration: Inactive; Registration expiration date Apr 11, 2015

Registration

Entity structure: Corporate Entity (Tax Exempt)
Business start date: Jun 24, 1999 (27 years)
Location: Mont-Royal, QC
Purpose of registration: All Awards
Website: ibex.ca

† FY2026 obligations (provisional; DoD awards signed after Jul 29, 2026 are not yet public).

Contract actions that the Department of Defense both funds and awards are withheld at the source for 90 days, so DoD awards signed after Jul 29, 2026 are not yet public.

All federal contractors in QC How these figures are built

Source: SAM.gov entity registration and FPDS contract actions recorded under UEI JJ1KXAGP4CQ3. GovChime does not check exclusions.

Performance

Net obligations recorded under this UEI since FY2013. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.

Net obligations by fiscal year of action

FY2013: $5,850

Total across 1 fiscal year: $5,850

Capabilities

NAICS codes

325413IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING(primary)

SBA certifications

No certification in the SBA profile data.

Product and service codes (PSC)

6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS

Contracts

Latest awards and orders

N0018313P1285PoDepartment of DefenseDepartment of the NavyLatest action Jul 28, 2013

Contact Info

As of Oct 3, 2026. Source: SAM.gov Points of Contact.

SAM.gov registration for IBEX Pharmaceuticals Inc lists a physical address and a separate mailing address, along with 2 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.

Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).

Physical Address

5485 rue Paré

Mont-Royal, QC, H4P 1P7

CAN

Mailing Address

5485 rue Paré, Suite 100

Mont-Royal, QC, H4P 1P7

CAN

Government Business Contact

Solange Dohle

5485 rue Pare

Mont-Royal, QC

CAN

Electronic Business Contact

Solange Dohle

5485 rue Pare

Mont-Royal, QC

CAN

Additional Details

As of Oct 3, 2026. Source: SAM.gov Entity Registration.

IBEX Pharmaceuticals Inc has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires April 11, 2015.

Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.

Compliance & Risk Assessment

Source: SAM.gov FAR responses

Suspension/Debarment Status

SAM.gov registration reports no active exclusion

Public Display

Entity information is publicly displayed

Disaster Relief Registry

Not registered for disaster relief

Bonding Information

No bonding information provided

EDI

Not declared in SAM.gov

Business Structure

Source: SAM.gov

Profit Structure:For Profit Organization

Organization:Foreign Owned

Registration Details

Source: SAM.gov

Initial Registration

May 31, 2013

Last Update

Apr 11, 2015

Registration Activation

Active — Apr 11, 2014

Fiscal Year End

07/31

Country of Incorporation

CAN